Tag: copper-64
Clarity secures large-scale manufacturing agreement for copper-64
Clarity Pharmaceuticals, an Australia-based clinical-stage radiopharmaceutical company, has announced a manufacturing supply agreement aimed at scaling up copper-64 production, as the company advances its radiopharmaceutical development program toward potential commercialisation.Â
Featured Article
AMCA Impact Study highlights AI’s role in improving HVAC safety compliance
A new AMCA Impact Study has highlighted the growing challenge of helping HVAC contractors access reliable safety and compliance information quickly, particularly for small and medium-sized businesses operating in Australia's highly regulated construction environment.
